Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, Cardenal F, Sánchez JM, Gumerlock PH, Tarón M, Sánchez JJ, Danenberg KD, Danenberg PV, Rosell R.
Lord RV, et al. Among authors: danenberg pv, danenberg kd.
Clin Cancer Res. 2002 Jul;8(7):2286-91.
Clin Cancer Res. 2002.
PMID: 12114432
Clinical Trial.